EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Measuring Lp(a) particles with a novel isoform-insensitive immunoassay illustrates efficacy of muvalaplin

Craig A Swearingen, John H Sloan, Grace M Rhodes, Robert W Siegel, Nico Bivi, Yuewei Qian, Robert J Konrad, Michael Boffa, Marlys Koschinsky, John Krege, Giacomo Ruotolo, Stephen J Nicholls und 2 weitere

Journal of Lipid Research · 2025

DOI: 10.1016/j.jlr.2024.100723 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Lipid Research, 2025. Verfasst von Craig A Swearingen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA. Hauptthemen laut MEDLINE: Lipoprotein(a). Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipoprotein(a)HumansImmunoassayProtein IsoformsMaleRNA, Small InterferingFemale

Stichwörter der Autor:innen

Lipoprotein (a)antibodiesapolipoprotein (a)cardiovascular diseaseclinical trialsdrug therapyimmunoassayisoformlipoprotein (a) metabolismmuvalaplin

Substanzen

Lipoprotein(a)Protein IsoformsRNA, Small Interfering

Autor:innen und Institutionen

  • Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.
  • Robarts Research Institute, University of Western Ontario, London, ON, Canada.
  • Victorian Heart Institute, Monash University, Clayton, VIC, Australia.
  • Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: michael_laura@lilly.com.
  • Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: wen_yi1@lilly.com.

Zitieren

APA

Swearingen, C. A., Sloan, J. H., Rhodes, G. M., Siegel, R. W., Bivi, N., Qian, Y., Konrad, R. J., Boffa, M., Koschinsky, M., Krege, J., Ruotolo, G., Nicholls, S. J., Michael, L. F., & Wen, Y. (2025). Measuring Lp(a) particles with a novel isoform-insensitive immunoassay illustrates efficacy of muvalaplin. Journal of Lipid Research. https://doi.org/10.1016/j.jlr.2024.100723

Vancouver

Swearingen CA, Sloan JH, Rhodes GM, Siegel RW, Bivi N, Qian Y, et al. Measuring Lp(a) particles with a novel isoform-insensitive immunoassay illustrates efficacy of muvalaplin. Journal of Lipid Research. 2025. doi:10.1016/j.jlr.2024.100723

BibTeX
@article{Swearingen2025,
  author = {Swearingen, Craig A and Sloan, John H and Rhodes, Grace M and Siegel, Robert W and Bivi, Nico and Qian, Yuewei and Konrad, Robert J and Boffa, Michael and Koschinsky, Marlys and Krege, John and Ruotolo, Giacomo and Nicholls, Stephen J and Michael, Laura F and Wen, Yi},
  title = {Measuring Lp(a) particles with a novel isoform-insensitive immunoassay illustrates efficacy of muvalaplin},
  journal = {Journal of Lipid Research},
  year = {2025},
  doi = {10.1016/j.jlr.2024.100723}
}
Kostenlos starten →